No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
Craig-Hallum Maintains Grace Therapeutics(GRCE.US) With Buy Rating
Craig-Hallum Reaffirms Their Buy Rating on Grace Therapeutics (GRCE)
Grace Therapeutics Reports Steady Progress and Financials
Grace Therapeutics And 2 Other US Penny Stocks To Watch
Grace Therapeutics GAAP EPS of -$0.30 Beats by $0.06